Trials / Completed
CompletedNCT06875687
Prostaglandin Analog Eyelash Serum and Ocular Surface Health: A Prospective Study
Effects of a Prostaglandin Analog-Based Eyelash Serum on Ocular Surface Integrity and Tear Film Stability: A Prospective Interventional Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Seville · Academic / Other
- Sex
- Female
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This prospective interventional study investigates the effects of a prostaglandin analog-based eyelash serum on ocular surface integrity, tear film stability, and eyelash growth over six weeks. Nineteen healthy female participants applied the serum daily, with clinical assessments performed at baseline and post-treatment. The study adhered to ethical guidelines, and parameters such as tear film stability, tear volume, ocular hyperemia, and eyelash characteristics were evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prostaglandin Analog-Based Eyelash Serum | This intervention consists of a prostaglandin analog-based eyelash serum applied once daily to the upper eyelid margin for six weeks. The serum contains dechloro dihydroxy difluoro ethylcloprostenolamide (DDDE), a prostaglandin analog known to promote eyelash growth. The formulation also includes panax ginseng root extract, urtica dioica extract, panthenol, niacinamide, and biotinoyl tripeptide-1, which contribute to hair follicle nourishment. The study evaluates its effects on ocular surface integrity, tear film stability, and eyelash growth. |
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2025-02-28
- Completion
- 2025-02-28
- First posted
- 2025-03-13
- Last updated
- 2025-03-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06875687. Inclusion in this directory is not an endorsement.